Sophono, Inc., is a medical device manufacturer specializing in implantable, bone conduction hearing devices. The company's products are designed for individuals suffering from severe to profound hearing loss or impairment. The Alpha 1 is the only abutment-free, implantable, bone-anchored hearing device. Treating those with conductive hearing loss, mixed hearing loss, and single-ear deafness, the FDA-cleared product Alpha 1 eliminates the problematic abutment of devices by using magnets to affix external sound processors.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/27/12 | $7,000,000 | Series B |
Wexford Capital | undisclosed |
